Amova Asset Management Americas, Inc.

Position in NRIX — Nurix Therapeutics, Inc.

CIK 1480751 NEW YORK, NY

Position in NRIX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$23,858,788

+$5,551,025 QoQ

Shares Held

983,462

-16.7% QoQ

Ownership

0.948%

of shares outstanding

% of Portfolio

0.31%

of 13F equity value

Holder Rank

#27

of 210 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 81% Shared 0% None 19%

Healthcare · as of Jun 30, 2026

Amova Asset Management Americas, Inc. holds $354,236,903 across 20 Biotechnology names. NRIX ranks #4 (6.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BEAM	Beam Therapeutics Inc.	3,455,043	$118,577,075
2	CRSP	CRISPR Therapeutics AG	1,720,097	$93,814,090
3	NTLA	Intellia Therapeutics, Inc.	2,897,529	$49,026,190
4	NRIX	Nurix Therapeutics, Inc. This page	983,462	$23,858,788
5	RXRX	Recursion Pharmaceuticals, Inc.	5,511,687	$20,227,891
6	ARCT	Arcturus Therapeutics Holdings Inc.	1,960,458	$13,174,277
7	ABSI	Absci Corp	1,013,965	$11,751,854
8	PRME	Prime Medicine, Inc.	2,407,018	$8,881,896

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$23,858,788	983,462	-16.7%	Shares	Sole	2026-08-13
2026-03-31	$18,307,763	1,181,146	-8.5%	Shares	Sole	2026-05-07
2025-12-31	$24,481,809	1,290,554	-17.1%	Shares	Sole	2026-02-11
2025-09-30	$14,391,105	1,557,479	+12.1%	Shares	Sole	2025-11-12
2025-06-30	$15,823,830	1,389,274	+83.8%	Shares	Sole	2025-08-11
2025-03-31	$8,980,923	755,970	-4.2%	Shares	Sole	2025-05-07
2024-12-31	$14,868,942	789,222	+42.8%	Shares	Sole	2025-02-10
2024-09-30	$12,416,966	552,602	—	Shares	Sole	2024-11-07
No filing history on record for this holder in this stock.